A. Mariaggi

发表

Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France

S. Kernéis, P. Frange, F. Rozenberg, 2021, Open forum infectious diseases.

Transmission routes of SARS-CoV-2 among healthcare workers of a French university hospital in Paris, France: a case-control study

S. Kernéis, P. Frange, F. Rozenberg, 2020, medRxiv.

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients

F. Ginhoux, E. Solary, D. Drubay, 2022, eBioMedicine.

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

J. Casanova, Z. Amoura, N. Zahr, 2022, Annals of the Rheumatic Diseases.

HPV 16 in squamous cell carcinoma of 19th century tonsils.

C. Charpentier, S. Albert, D. Descamps, 2016, The Lancet Oncology.

SARS-COV-2 IgG antibody response in pregnant women at delivery

Y. Ville, D. Luton, V. Tsatsaris, 2020, Journal of Gynecology Obstetrics and Human Reproduction.

Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)–Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58

C. Charpentier, A. Couvelard, D. Descamps, 2018, The Journal of infectious diseases.

Immunoblots may not be effective in confirming the recency of HIV-1 infection.

L. Meyer, C. Goujard, A. Chéret, 2021, Journal of virological methods.

LONG-TERM IMMUNITY TO MEASLES AFTER ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION: FACTORS ASSOCIATED WITH SEROPROTECTION BEFORE REVACCINATION: Immunity to measles after HCT.

F. Rozenberg, C. Cordonnier, C. Pautas, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

X. Mariette, J. Avouac, F. Rozenberg, 2022, RMD Open.

Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases

J. Avouac, F. Rozenberg, J. Morel, 2021, Joint Bone Spine.

Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection

Y. Allanore, J. Avouac, F. Rozenberg, 2022, Rheumatology.

SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population

V. Calvez, C. Charpentier, C. Delaugerre, 2021, Science of The Total Environment.